Strategies for developing novel therapeutics for sensorineural hearing loss by Takayuki Nakagawa
MINI REVIEW ARTICLE
published: 16 September 2014
doi: 10.3389/fphar.2014.00206
Strategies for developing novel therapeutics for
sensorineural hearing loss
Takayuki Nakagawa*
Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Edited by:
Hiroshi Hibino, Niigata University,
Japan
Reviewed by:
Kazuharu Furutani, Osaka University
Graduate School of Medicine, Japan
Tetsuo Morihana, Osaka University
Graduate School of Medicine, Japan
*Correspondence:
Takayuki Nakagawa, Department of
Otolaryngology, Head and Neck
Surgery, Graduate School of
Medicine, Kyoto University,
Kawaharacho 54, Shogoin, Sakyoku,
Kyoto 606-8507, Japan
e-mail: tnakagawa@
ent.kuhp.kyoto-u.ac.jps
Sensorineural hearing loss (SNHL) is a common disability in the world; however, at
present, options for the pharmacological treatment of SNHL are very limited. Previous
studies involving human temporal bone analyses have revealed that the degeneration of
the cochlea is a common mechanism of SNHL. A major problem for the development of
novel pharmacotherapy for SNHL has been the limited regeneration capacity in mammalian
cochlear cells. However, recent progress in basic studies has led to several effective
strategies for the induction of regeneration in the mammalian cochlea, in accordance with
the stage of degeneration. In addition, recent advances in the identiﬁcation of human
deafness genes and their characterization in mouse models have elucidated cellular and/or
molecular mechanisms of SNHL, which will contribute to clarify molecular targets of
pharmacotherapy for treatment of SNHL.
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BACKGROUND
Hearing impairment has been the most common cause of dis-
ability worldwide. Hearing impairment can be subdivided into
two types, conductive and sensorineural hearing loss (SNHL).
Although conductive hearing loss is largely overcome by surgical
treatment, therapeutic options for SNHL are limited to hearing
aids and cochlear implants, if the hearing loss has been reversed.
In SNHL with acute onset, pharmacotherapy sometimes cures
hearing loss. However, pharmacotherapy options for SNHL are
very limited. Therefore, researchers have actively sought novel
therapeutics for the treatment of SNHL.
Sensorineural hearing loss is largely caused by the degen-
eration of the cochlea, a sensory organ for hearing. Studies
of human temporal bones have revealed that SNHL can be
caused by the degeneration of various components of the cochlea
(Merchant and Nadol, 2010). Among the various types of cochlear
cells, hair cells, which convert sound stimuli to neural signals,
have been a central therapeutic target for developing novel thera-
peutics. The spiral ganglion neurons (primary auditory neurons)
transmit auditory stimuli from the cochlea to the central nervous
system. Spiral ganglion neurons are crucial for clinical beneﬁts
of a cochlear implant, which is a device that improves hearing
in deafened patients. A stimulator of the cochlear implant, with
an array of up to 24 electrodes, is surgically inserted into the
cochlea and directly stimulates spiral ganglion neurons. There-
fore, a loss of spiral ganglion neurons undermines the clinical
beneﬁts of cochlear implants. For these reasons, spiral ganglion
neurons also have been an important therapeutic target for devel-
oping pharmacotherapies for SNHL. Beside hair cells and spiral
ganglion neurons, there are a number of other cochlear compo-
nents that are included in a list of possible therapeutic targets.
The stria vascularis and spiral ligament in the cochlear lateral
wall are among them. These components play key roles in the
maintenance of a high concentration of potassium ions in the
endolymph, which is necessary for the depolarization of hair
cells.
In mammals, the cochlear components described above have
virtually no regenerative capacity; this situation is thought to
be an obstacle for the development of novel therapeutics for
SNHL. However, recent studies have demonstrated that the mam-
malian cochlea does have the capacity for regeneration, although
it is limited. Several challenges for promotion of the limited
capacity for regeneration in mammalian cochleae have been
overcome. In the mammalian cochlea, researchers have iden-
tiﬁed stem cell-like cells (Li et al., 2003; Oshima et al., 2007;
Taniguchi et al., 2012; Jan et al., 2013). The functional restora-
tion of mammalian cochleae was achieved via several challenging
strategies in experimental animals (Izumikawa et al., 2005; Okano
et al., 2005; Chen et al., 2012; Mizutari et al., 2013; Tona et al.,
2014a). However, the quality of functionality of the regener-
ated cochleae is not satisfactory. Therefore, new approaches
are required for the development of novel therapeutics for
SNHL.
Although strategies for the restoration of damaged cochleae
are urgently required, more detailed information on therapeutic
targets and the development of diagnostic tools are also neces-
sary. Many studies have been focused on morphological ﬁndings
in human temporal bones, i.e., the following four classical types
of SNHL etiology: the loss of hair cells, loss of spiral ganglion
neurons, degeneration of the stria vascularis, and combinations
(Merchant and Nadol, 2010).
Recent progress in the identiﬁcation of human deafness genes
and their characterization in mouse models have elucidated cellu-
lar and molecular mechanisms behind SNHL (Hereditary Hear-
ing Loss Homepage: http://hereditaryhearingloss.org/), which
indicate more detailed targets for the treatment of SNHL.
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In this review, we focus on strategies for the induction of regen-
eration in the mammalian cochlea and on new therapeutic targets
for SNHL.
STRATEGIES FOR INDUCTION OF REGENERATION
The sensory hair cell has been the center of attention in studies
of the regeneration of inner-ear. Therefore, in this section, the
regeneration of hair cells forms the basis of discussion of possible
strategies for development of novel therapeutics.
Before hair cells completely disappear from the organ of Corti,
the induction of self-repair may be a pragmatic strategy. For this
purpose, we propose a two-step process. The ﬁrst step is the pro-
motion of the survival of hair cells and the second step is the
reconstruction of the components of hair cells. Several therapeutic
agents that promote survival or protect from cell death have been
reported. Some of such candidates have been tested for efﬁcacy
and safety in clinical trials (Suckfuell et al., 2007; Nakagawa et al.,
2010). Notably, both clinical trials used local application of drugs
to the cochlea, which has several advantages including delivery of
drugs at high concentrations, but requires surgical invasiveness.
A close relation between hair cell death and c-jun N-terminal
kinase (JNK) has been reported in animal experiments (Pirvola
et al., 2000; Wang et al., 2003; Murai et al., 2008). Recently, AM-
111, a peptide JNK inhibitor, has been examined its potential for
prevention of acoustic trauma in humans (Suckfuell et al., 2007).
A clinical trial of recombinant human insulin-like growth factor-1
(IGF-1) in sudden deafness has also been performed (Nakagawa
et al., 2010), based on the results in animal experiments (Lee et al.,
2007; Fujiwara et al., 2008). More recently, mechanisms of IGF-1
actions on the cochlear sensory epithelium have been demon-
strated (Hayashi et al., 2013, 2014). In contrast to the promotion of
the survival, there are no speciﬁc reports describing the induction
of the reconstruction of cellular components, such as stereocil-
iary bundles, in damaged hair cells. In this regard, it would be
worthwhile to devote more research efforts to the mechanisms
underlying the development and maintenance of the stereociliary
bundles.
After hair cells are gone, three possible strategies can be uti-
lized depending on the condition of the remaining supporting
cells. If sufﬁcient numbers of healthy supporting cells are still
present in the organ of Corti, then the induction of the trans-
differentiation of supporting cells into hair cells can be a viable
strategy. Hair and supporting cells share a common progenitor
during development. The manipulation of Notch signaling has
been used for induction of transdifferentiation of supporting cells.
The transdifferentiation of supporting cells into hair cells was ﬁrst
demonstrated by gene transfer. The introduction of the Atoh1
gene into supporting cells using an adenoviral vector induces the
transdifferentiation of supporting cells into hair cells (Zheng and
Gao, 2000; Izumikawa et al., 2005). In theory, the inhibition of
Notch signaling upregulates Atoh1. In addition, the pharmaco-
logical inhibition of Notch signaling has also been successfully
used for this purpose. For example, the inhibition of Notch sig-
naling using γ-secretase inhibitors increases Atoh1 expression in
neonatal cochleae, leading to the excessive generation of hair cells
(Yamamoto et al., 2006). However, in adult cochleae, no expression
of Notch ligands and receptors is virtually detectable in supporting
cells. For some time after damage, the temporary activation of
Notch signaling is detected even in adult cochleae (Hori et al.,
2007; Batts et al., 2009). The topical application of a γ-secretase
inhibitor to cochleae results in the induction of hair cell (Hori
et al., 2007; Mizutari et al., 2013; Tona et al., 2014a). At present,
hearing restoration via this approach is not satisfactory, and the
therapeutic time window is narrow. γ-Secretase inhibitors have
gained considerable attention because they inhibit Notch signal-
ing and the formation of the β-amyloid peptide. Because of the
latter effect, γ-secretase inhibitors have been the main focus of
rational drug design in the ﬁeld of Alzheimer’s disease research.
This situation means that various effective γ-secretase inhibitors
will soon become available. An extensive search for the best γ-
secretase inhibitor for the induction of hair cell is necessary for
the clinical application of this strategy.
In the two directions – self-repair and transdifferentiation –
pharmacological treatment is expected to become mainstream.
For the clinical application of basic research in this ﬁeld, investiga-
tors require drug delivery systems capable of delivering therapeutic
molecules to cochlear cells. In parallel with the rational drug
design, a lot of research effort in the last decadewent into the devel-
opment of drug delivery systems for the cochlea (Nakagawa and
Ito, 2011; Pritz et al., 2013; Staecker and Rodgers, 2013). Among
such systems, we clinically applied the gelatin hydrogel, which
is suitable for the sustained delivery of peptides or proteins to
cochlear cells (Nakagawa et al., 2010). Depending on the chemical
characteristics of a therapeutic molecule, the optimal drug deliv-
ery system is likely to be different. Therefore, the development
of drug delivery systems for speciﬁc drugs or biologics should be
mentioned among the key challenges for the development of novel
treatments of SNHL.
When the number of the remaining supporting cells in the
cochlea is insufﬁcient, then the induction of the proliferation in
supporting cells is required. In the mammalian cochlea, the pro-
liferation of cell rarely occurs after birth, whereas in the avian
cochlea (basilar papilla), supporting cells proliferate in response
to hair cell loss (Stone and Cotanche, 2007). In the avian cochlea,
both the transdifferentiation of supporting cells into hair cells
and proliferation of supporting cells, followed by differentiation
into hair cells, takes place (Stone and Cotanche, 2007). To induce
the proliferation of supporting cells in the mammalian cochlea,
the downregulation of cell cycle inhibitors is a logical step. The
major cell cycle inhibitor in mammalian supporting cells is p27,
an inhibitor of cyclin-dependent kinase. The genetic deletion of
p27 results in the excessive generation of hair cells (Chen and
Segil, 1999; Löwenheim et al., 1999). A knockdown of p27 in sup-
porting cells induces re-entry of these cells into the cell cycle,
but the majority of the supporting cells that have re-entered
the cell cycle then undergo apoptosis (Ono et al., 2009). There-
fore, cell cycle re-entry by supporting cells is not sufﬁcient for
the regeneration of hair cells, suggesting that some other char-
acteristics of supporting cells also need to be altered. Recently,
several challenges for the induction of the dedifferentiation of
supporting cells have been described (Burns et al., 2012; Lou et al.,
2013). In those studies, transcription factors for the generation
of inducible pluripotent stem (iPS) cells were utilized for the
induction of the dedifferentiation of inner ear cells. However,
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the effects of iPS factors in the inner ear have not been explored
in vivo.
Another option when supporting cells are severely damaged is
the introduction of exogenous stem cells into the cochlea. The
cell transplantation approach to the regeneration of hair cells has
gained considerable attention because stem cells are believed to
accumulate in the damaged sites and have the potential for the
repair of damaged tissues. On the other hand, the migration
of transplanted stem cells into a damaged sensory epithelium of
the inner ear is rarely observed (Tateya et al., 2003). In addition,
because of the high concentrations of potassium, the conditions
in the endolymphatic space of the inner ear are not conducive
to the survival of a transplant. Recently, the intrinsic stem cell
populations in the inner ear have attracted a lot of interest as
an alternative to the introduction of exogenous stem cell-derived
cells into cochleae (Li et al., 2003; Oshima et al., 2007; Taniguchi
et al., 2012; Jan et al., 2013). However, there is no evidence that
internal stem cell populations participate in the maintenance of
mammalian cochleae. In addition, the number of stem cell-like
cells in the inner ear rapidly decreases because of functional mat-
uration. It is necessary to ﬁnd a way to enhance the self-renewal
potential of endogenous stem cells and induce targeted migration
of endogenous stem cells to a damaged tissue. Researchers also
require methods for steering the differentiation of endogenous
stem cells into the cell lineages of interest.
THERAPEUTIC TARGETS IN SNHL
Recent advances in the identiﬁcation of human deafness genes and
their physiological characterization in mouse models have eluci-
dated precise cellular mechanisms underlying SNHL (Saﬁeddine
et al., 2012). Molecules involved in cochlear ionic homeostasis,
mechanoelectrical transduction in the hair bundle, or synaptic
transmission by the inner hair cells can be targets for the treatment
of SNHL.
The stria vascularis and spiral ligament in the cochlear lateral
wall perform crucial functions in the maintenance of cochlear
ion homeostasis (Patuzzi, 2011). Ion channels and cell–cell junc-
tions in the stria vascularis and spiral ligament participate in the
maintenance of ion homeostasis in the cochlear ﬂuids (Kikuchi
et al., 2000). Among the various channels and junctions in these
cochlear components, the gap junction is particularly important
because it is involved in the maintenance of high potassium lev-
els in endolymph; the mutation of genes associated with the
gap junction is the most frequent cause of congenital SNHL
(Cohen-Salmon et al., 2002; Schütz et al., 2011). A recent study
demonstratedbeneﬁts of an in utero gene transfer for the treatment
of congenital SNHL associated with the gap junction in a mouse
model (Miwa et al., 2013). Thanks to the progress in genetic test-
ing for deafness genes (Shearer et al., 2013), the number of patients
with mutations in gap junction-associated genes will increase. In
addition, the screening systems for deafness genes are becom-
ing popular. Therefore, the restoration of gap junction-associated
molecules will become a hot topic in the ﬁeld of translational
research of SNHL.
The ﬁrst step in the conversion of sound stimuli into neu-
ral signals is a tilt of stereociliary bundles located at the top of
hair cells. In the stereociliary bundles, there are several types of
molecules that are essential for hearing, such as channels and
junctions (Richardson et al., 2011; Fettiplace and Kim, 2014). In
addition, the rootlet of the stereociliary bundles is also crucial
for the maintenance of the stereocilia. Therefore, several types of
molecules associated with the stereocilia can serve as therapeutic
targets for SNHL. In the process of self-repair of hair cells, the
restoration of the stereocilia is necessary for the functionality of
hair cells. Therefore, studies aimed at the elucidation of the mech-
anisms behind the maintenance of the stereociliary bundle are
required for increasing the efﬁcacy of the self-repair approach.
Synaptic contacts between inner hair cells and spiral gan-
glion neurons are among the practical targets for the devel-
opment of novel therapeutics for SNHL. Similar to the lateral
wall and stereociliary bundle, the importance of synaptic con-
tacts between inner hair cells and spiral ganglion neurons has
been revealed by the discovery of the deafness genes associ-
ated with the ribbon synapse (Moser et al., 2013). The ribbon
synapse is speciﬁc for the retina and inner ear and plays a crucial
role in their functioning (Uthaiah and Hudspeth, 2010; Saﬁed-
dine et al., 2012). Furthermore, the degeneration of synaptic
contacts between inner hair cells and spiral ganglion neurons
has been frequently implicated in the pathogenesis of SNHL
caused by various factors, such as noise, aging, and oto-
toxic drugs (Kujawa and Liberman, 2009; Lin et al., 2011; Liu
et al., 2013; Sergeyenko et al., 2013). Therefore, these synap-
tic contacts have become an important therapeutic target in
SNHL.
Synaptic contacts between inner hair cells and spiral ganglion
neurons have the capacity for spontaneous regeneration (Wang
and Green, 2011). Therefore, the induction of their regenera-
tion may be a practical treatment strategy. Previously, the search
for effective protective agents for hair cells was the main strat-
egy for the development of novel therapeutics for SNHL. In the
coming decade, synapses between inner hair cells and spiral gan-
glion neurons are expected to become a center of attention in this
type of translational research. In addition, the potential of gene
therapy for restoration of VGLUT3, which is also an important
molecule for the functionality of synaptic contacts between inner
hair cells and spiral ganglion neurons, has been reported (Akil
et al., 2009). Therefore, synaptic contacts between inner hair cells
and spiral ganglion neurons will become a target of attention for
the translation of gene therapy for the treatment of hearing.
FUTURE PERSPECTIVES
In this study, we reviewed the present status and feasibility of the
following four strategies for the inductionof regeneration inmam-
malian cochlea: self-repair, transdifferentiation, dedifferentiation,
and transplantation. Studies on these strategies have resulted in
substantial progress toward clinical applications. In particular,
novel self-repair techniques have already been tested for safety
and efﬁcacy in clinical trials.
For further acceleration of the exploration of novel therapeu-
tics, the establishment of new screening systems may be the key
challenge. Some studies demonstrated the efﬁcacy of zebraﬁsh
models for this purpose (Esterberg et al., 2013). However, the
drugs that have been identiﬁed and characterized using zebraﬁsh
screening systems have yet to be applied to clinical use.
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Another promising screening tool is human iPS cells. The otic
induction of pluripotent stem cells was recently reported (Oshima
et al., 2010; Koehler et al., 2013; Ronaghi et al., 2014). Therefore, in
theory, it is possible to generate some phenotypes of inner ear cells,
especially sensory hair cells, fromhuman iPS cells. Human iPS cell-
derived cochlear cells could become auseful tool for the assessment
of the efﬁcacy of SNHL drugs and identiﬁcation of differences in
pharmacological effects among species. At present, the efﬁciency
of otic inductionby thepublishedmethods is inadequate, i.e., these
techniques cannot generate sufﬁcient numbers of inner ear cells
for translational research. Further studies are required to reﬁne
the induction methods that can be utilized for research of disease-
speciﬁc iPS cells.
The development of relevant diagnostic methods is also impor-
tant. To fully utilize the detailed information generated by the
studies of human deafness genes, clinical researchers require more
focused and accurate diagnostic tools. At present, the functional-
ity of outer hair cells is evaluated by otoacoustic emission. Recent
studies have demonstrated that the amplitude of wave 1 in ABRs is
closely related to the level of the degeneration of synaptic contacts
between inner hair cells and spiral ganglion neurons (Kujawa and
Liberman, 2009; Sergeyenko et al., 2013). The clinical utility of the
measurement of ABR wave 1 amplitudes will be examined in the
near future. In addition, with respect to functional analysis, more
detailed morphological studies of cochleae are worthwhile. The
beneﬁts of an optical coherence tomograph have been recently
evaluated (Gao et al., 2011, 2013; Kakigi et al., 2013; Tona et al.,
2014b).
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